Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Med Sci (Paris). 2024 Jun-Jul;40(6-7):544-549. doi: 10.1051/medsci/2024082. Epub 2024 Jul 8.
ABSTRACT
The enteric nervous system (ENS), often called the “second brain”, plays a crucial role in regulating digestive functions. Dysfunctions of the ENS are associated with several diseases such as Parkinson’s disease. Recent studies suggest that early digestive disorders, notably chronic constipation, may be early signs of this neurodegenerative disease. Three-dimensional imaging of the ENS offers new insights into early diagnosis, in particular through the analysis of intestinal biopsies. This new research axis raises questions about the intestinal cause of Parkinson’s disease, and opens the door to a better understanding and earlier treatment of this disease.
PMID:38986099 | DOI:10.1051/medsci/2024082
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
The gut, a whistleblower, in the early stages of Parkinson’s disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
The Gut-Brain Axis in Parkinson's Disease Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice Genomic stress in diseases stemming from defects in the second brain Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies Remote optogenetic control of the enteric nervous system and brain-gut axis in freely-behaving mice enabled by a wireless, battery-free optoelectronic device The regulation of enteric neuron connectivity by semaphorin 5A is affected by the autism-associated S956G missense mutation Psychoneuroimmunology: when immunity meets behavioural aspects in an allergic context Subtype-specific pathological signatures in grey matter heterotopia Fighting hypertension, diabetes and physical inactivity to prevent dementia Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health Enteric neuropathy and the vagus nerve: Therapeutic implications Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: An updated overview Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases Artificial Intelligence in Parkinson's Disease: Early Detection and Diagnostic Advancements Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders Advancing the Frontier: Neuroimaging Techniques in the Early Detection and Management of Neurodegenerative Diseases The role of AI and machine learning in the diagnosis of Parkinson's disease and atypical parkinsonisms Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging Sleep patterns, genetic susceptibility, and digestive diseases: A large-scale longitudinal cohort study Influence of human gut microbiome on the healthy and the neurodegenerative aging The immune system in Parkinson's disease: what we know so far Gut microbiota-astrocyte axis: new insights into age-related cognitive decline Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer's disease Understanding REM Sleep Behavior Disorder through Functional MRI: A Systematic Review An improved method for diagnosis of Parkinson's disease using deep learning models enhanced with metaheuristic algorithm Drug repurposing for neurodegenerative diseases The Role of Alpha-Synuclein in Neurodevelopmental Diseases DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation The Role of Alpha-Synuclein in Neurodevelopmental Diseases The Role of Alpha-Synuclein in Neurodevelopmental Diseases Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases Fractional Anisotropy is a More Sensitive Diagnostic Biomarker Than Mean Kurtosis for Patients with Parkinson Disease with Cognitive Dysfunction: A Diffusional Kurtosis Map Tract-Based Spatial Statistics Study Generation of induced pluripotent stem cells (NIMHi015-A) from a Parkinson's Disease patient harbouring a homozygous Exon 3 deletion in the PRKN gene Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience Omega-3 polyunsaturated fatty acids play a protective role in a mouse model of Parkinson's disease by increasing intestinal inducible Treg cells The Relationship between SNAP25 and Some Common Human Neurological Syndromes Gut-liver axis: Potential mechanisms of action of food-derived extracellular vesicles Neuroimaging for Early Diagnosis of Alzheimer's Disease: a Review Sympathetic 123I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging Transferrin-conjugated magnetic nanoparticles for the isolation of brain-derived blood exosomal MicroRNAs: A novel approach for Parkinson's disease diagnosis The gut-liver axis in fatty liver disease: role played by natural products The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson's disease A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets Amyloid, Crohn's disease, and Alzheimer's disease - are they linked? Improving Medication Management for Inpatients with a Secondary Diagnosis of Parkinson Disease
Evidence Blueprint
The gut, a whistleblower, in the early stages of Parkinson’s disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
The gut, a whistleblower, in the early stages of Parkinson’s disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
The Gut-Brain Axis in Parkinson's Disease Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice Genomic stress in diseases stemming from defects in the second brain Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS The enteric nervous system deficits in autism spectrum disorder Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders Remote optogenetic control of the enteric nervous system and brain-gut axis in freely-behaving mice enabled by a wireless, battery-free optoelectronic device The regulation of enteric neuron connectivity by semaphorin 5A is affected by the autism-associated S956G missense mutation Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway Psychoneuroimmunology: when immunity meets behavioural aspects in an allergic context Subtype-specific pathological signatures in grey matter heterotopia Fighting hypertension, diabetes and physical inactivity to prevent dementia Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease Peripheral neuronal activation shapes the microbiome and alters gut physiology Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health Gastrointestinal Diseases, Genetic Risk, and Incident Dementia: A Prospective Cohort Study in 352,463 Middle-Aged Adults Enteric neuropathy and the vagus nerve: Therapeutic implications EEG-Based PD Classification Model Coupled with Machine Learning Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication The Body, the Brain, the Environment, and Parkinson's Disease Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: An updated overview Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies Calprotectin in Parkinsonian Disease: Anticipation and Dedication Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases Getting to the heart of Lewy body disease Translocation of gut commensal bacteria to the brain Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain axis Artificial Intelligence in Parkinson's Disease: Early Detection and Diagnostic Advancements Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders Gut microbiota bridges the iron homeostasis and host health An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside Early onset Parkinson's disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report The gut microbiota-brain axis in neurological disorder Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson's Disease as a Multi-System Process Synaptic loss and its association with symptom severity in Parkinson's disease Parkinson's disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes Loss of ASD-related molecule Cntnap2 affects colonic motility in mice Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure Advancing the Frontier: Neuroimaging Techniques in the Early Detection and Management of Neurodegenerative Diseases Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis The role of AI and machine learning in the diagnosis of Parkinson's disease and atypical parkinsonisms The systemic immune response in Parkinson's disease: focus on the peripheral immune component Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights Global biomarker trends in Parkinson's disease research: A bibliometric analysis The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets Neuroimaging and plasma evidence of early white matter loss in Parkinson's disease with poor outcomes Neuropharmacological insights into Gardenia jasminoides Ellis: Harnessing therapeutic potential for central nervous system disorders Boundaries and integration between microbiota, the nervous system, and immunity Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non-alcoholic fatty liver disease From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers Pleiotropy with sex-specific traits reveals genetic aspects of sex differences in Parkinson's disease Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management